Latest news, press releases, and SEC filings for Axsome Therapeutics Inc (AXSM) https://caymanjournal.com/stock/AXSM en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 00:58:55 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is an 8-K filing, which is like a "breaking news" report a public company sends to the SEC. It announces a significant event: Axsome has bought the rights to a new experimental drug called balipodect from Takeda. The attached press release (Exhibit 99.1) gives all the https://caymanjournal.com/stock/AXSM/sec-filing/0001193125-26-135669 https://caymanjournal.com/stock/AXSM/sec-filing/0001193125-26-135669 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing